about
Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical studyDecision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressedSurvival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery.Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis.Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients.The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial.Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014.Multidisciplinary discussion and management of rectal cancer: a population-based study.Comparative analysis of risk factors for pathological fracture with femoral metastases.Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer.Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer GroupInternational consensus guidelines on Clinical Target Volume delineation in rectal cancer.Low rectal cancer: a call for a change of approach in abdominoperineal resection.Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferencesImprovement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration.The EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer: validation of the Dutch version.Methodologic evaluation of adaptive conjoint analysis to assess patient preferences: an application in oncology.Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist.Prediction in rectal cancer.EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.Organ preservation in rectal cancer: have all questions been answered?Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer.Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands.Predictive Value of Six Prognostic Scoring Systems for Spinal Bone Metastases: An Analysis Based on 1379 Patients.Silver clear nylon dressing is effective in preventing radiation-induced dermatitis in patients with lower gastrointestinal cancer: results from a phase III study.Patients' preferences for low rectal cancer surgery.Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study.Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.Considering patient values and treatment preferences enhances patient involvement in rectal cancer treatment decision making.Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.Course of Quality of Life After Radiation Therapy for Painful Bone Metastases: A Detailed Analysis From the Dutch Bone Metastasis Study.Acute toxicity after a diverting stoma and spacer prior to chemoradiation in locally advanced rectal cancer.The beneficial local and abscopal effect of splenic irradiation in frail patients with chronic lymphocytic leukaemia.
P50
Q24801703-949FE9C8-86E0-4A17-8F3A-B1F4817ED450Q30409468-BB16EBD5-D431-42D4-BFEE-12AE216DC1ADQ31122203-DC682D39-7B34-40E3-93C9-CD87F2346C58Q33214914-2EF90475-3133-4AFA-8DB1-ACEA1260C6E0Q33753472-79F3E67F-6C7E-4398-A461-BCF65236D21BQ34101866-E2C85C1C-F4F6-4356-B7EC-C6A69BCE25F3Q34462455-E5F5F02A-DE62-46A1-A84F-D7C76866B317Q34540951-F5B2941F-90B0-418C-949D-C9D4FCABC6D9Q35002552-057A9F19-7DB7-44DE-BAF2-D3C1E7A716D8Q35154362-DAFB82D0-A079-44BE-9FBC-9930D234E9ACQ35790551-36E63D70-B99A-4CB0-B802-852ED3CF62A7Q36052466-2E0B1C04-A416-4A2B-8215-D455E71E1169Q36083371-7DD0739D-EB97-423D-84E7-8ABF1FE57D78Q36087573-F72618BA-3C8D-4B53-AAD6-A41308FDEFCCQ36104628-F9DA95C3-CCA4-49DD-851C-AEA3866D5A2FQ36345467-E2C1D164-3027-47C7-BF12-8740FE71D68FQ36611201-D9713647-83E2-48D9-AA14-4D024F6FC05EQ36838484-A7854656-F50B-486C-88D9-3EC85621F08BQ36882725-C2758667-D283-4E12-A6F9-7BFB76D0B23CQ36969568-4629A0E3-92DF-4329-8B48-0AC51A831C5DQ37332615-4547EE3B-BDF9-4A28-B8AA-076915F01E61Q37574874-27C9E1A8-D7A2-479C-8251-FA4F8AFFFC3CQ37990115-33D8B589-B8C4-4D8F-AE1A-279D99A9B5ABQ38158829-B0AE93C3-70DC-4CDB-B802-B4C9C1DD44AEQ38228979-2E70BF81-0E42-450D-A2B3-CC445AAD04B6Q38338977-68DFEA78-9957-4D67-B7A3-DE789EE45078Q38856233-B900CC4E-838D-471D-8527-F3E000042BF2Q38870590-51514B46-5243-4627-8257-AA6943E2E020Q39907331-70603A32-01BA-42F2-90A3-B3E045269E15Q39998079-5373E941-ECBF-4F4D-B6E7-1F26298ED48FQ40005040-14B1A03E-A24F-4BC0-B7BA-78D1AF26C68CQ40038182-70528BBC-4966-4920-B227-A3E9068427CCQ40168799-5F133782-017F-4271-A6D7-540C5BE41B41Q40263194-149226B0-C006-4F00-87CE-2859637BB681Q40392520-36C12B96-7F83-4689-AB94-7BA628737017Q40537586-7C2F2B2B-5E5E-460B-B775-EB46609C45E3Q40634940-0A49F366-1455-4AF8-AC5F-23DA9DAF10A8Q40694832-6186B523-825E-4EFB-8DDE-A5C770D2AFA7Q40723768-121563DE-9504-4DBB-8E28-71696B189C36Q40830129-342DA831-50EC-4040-B18A-258ACCE4DB79
P50
description
researcher ORCID ID = 0000-0003-0189-5953
@en
wetenschapper
@nl
name
Corrie Marijnen
@ast
Corrie Marijnen
@en
Corrie Marijnen
@es
Corrie Marijnen
@nl
type
label
Corrie Marijnen
@ast
Corrie Marijnen
@en
Corrie Marijnen
@es
Corrie Marijnen
@nl
altLabel
C. Marijnen
@nl
prefLabel
Corrie Marijnen
@ast
Corrie Marijnen
@en
Corrie Marijnen
@es
Corrie Marijnen
@nl
P108
P1006
P1006
P31
P496
0000-0003-0189-5953
P7449
PRS1301830